Drug Type Small molecule drug |
Synonyms AP 611, AP-611, AP-611074 + [2] |
Target |
Mechanism HPV E1 inhibitors(HPV E1 inhibitors), HPV E2 inhibitors(HPV E2 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H36BrN3O4 |
InChIKeyIYWCUQWSZXLRNG-UHFFFAOYSA-N |
CAS Registry1075798-37-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Condylomata Acuminata | Phase 2 | AR | 01 Jan 2016 | |
Condylomata Acuminata | Phase 2 | CL | 01 Jan 2016 | |
Condylomata Acuminata | Phase 2 | EC | 01 Jan 2016 | |
Condylomata Acuminata | Phase 2 | RS | 01 Jan 2016 | |
Human Papillomavirus Infection | Phase 2 | FR | 28 Feb 2012 |